SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/09/2025 07:31 PDT] SIGA Expected to Trade Up After Bullish Patterns Develop
• [05/07/2025 06:57 PDT] SIGA Expected to Trade Down Short Term
• [05/01/2025 07:12 PDT] SIGA Expected to Trade Down After Bearish Patterns Develop
• [04/28/2025 08:05 PDT] SIGA Expected to Trade Up Short Term
• [04/15/2025 07:44 PDT] SIGA Expected to Trade Up After Bullish Patterns Develop
• [04/10/2025 07:37 PDT] SIGA Expected to Trade Up After Bullish Patterns Develop
• [04/09/2025 07:19 PDT] SIGA Expected to Trade Up After Bullish Patterns Develop